Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2014;13(3):353-7.
doi: 10.4161/cc.27769. Epub 2014 Jan 9.

Reconciliation of classification systems defining molecular subtypes of colorectal cancer: interrelationships and clinical implications

Anguraj Sadanandam  1 , Xin Wang  2 , Felipe de Sousa E Melo  3 , Joe W Gray  4 , Louis Vermeulen  5 , Douglas Hanahan  6 , Jan Paul Medema  3
Affiliations
Comment

Reconciliation of classification systems defining molecular subtypes of colorectal cancer: interrelationships and clinical implications

Anguraj Sadanandam et al. Cell Cycle. 2014.

Abstract

Recently we published two independent studies describing novel gene expression-based classifications of colorectal cancer (CRC). Notably, each study stratified CRC into a different number of subtypes: one reported 3 subtypes, whereas the second highlighted 5. Given that each ascribed clinical significance, distinctive biology, and therapeutic prognosis to the different subtypes, we sought to reconcile this apparent incongruity in subtype stratification of CRC, and to interrelate the results. To do so, we each evaluated the other's data sets and analytical methods and discovered that the subtypes and their classifiers are, in fact, clearly related to each other; indeed, the 5 subtype outcomes can be coalesced into the same three. In addition to presenting this clarification, we briefly discuss how both classification methods can be viewed within the broader literature on CRC subtypes, and potentially applied.

Keywords: CIMP; MSI; cancer subtypes; cetuximab; colorectal cancer; consensus clustering; serrated pathway; therapy resistance.

PubMed Disclaimer

Figures

None
Figure 1. Overview of CRC classification studies. (A and B) Graphic showing the clinical and biological characteristics and gene signatures of Colon Cancer Subtypes (CCS) (A) and CRCassigner subtypes (B). SSA, sessile serrated adenoma; TA, transit-amplifying; CR-TA, cetuximab-resistant TA; CS-TA, cetuximab-sensitive TA; DFS, disease-free survival.
None
Figure 2. Relationships of colorectal cancer subtype classifications. (A and B) Heatmaps depict the AMC-AJCCII-90 data set classified according to the CRCassigner signature (A) and the Sadanandam et al. core data set classified based on the CCS classification (B). Columns represent patients; rows indicate CRCassigner genes (A) or CCS classifier genes (B). Colors represent relative gene expression levels; blue signifies low expression, and brown high expression. (C and D) Heatmaps indicate association of CRCassigner subtype samples (left) with CCS group samples (top) for the AMC-AJCCII-90 set (C) and the Sadanandam et al. core data set (D). Colors indicate significance of association; green signifies a low association, and red a high association. P values are determined using hypergeometric tests.
None
Figure 3. Validation in the TCGA data set. (A) Heatmap depicts the TCGA data set classified by both taxonomies. Columns represent patients; rows indicate genes from the CCS classifier. Colors represent relative gene expression levels; blue signifies low expression, and brown, high expression. (B) Heatmap indicates association of CRCassigner subtype samples (left) with CCS group samples (top) for the TCGA set. Colors indicate significance of association; green signifies a low association, and red a high association. P values are determined using hypergeometric tests. (C) Graph depicts the association of clinical and (epi)genetic characteristics with both classification methods for the TCGA data set. Features that are significantly associated with both classification schemes are indicated. P values are determined using Chi-square tests.
See this image and copyright information in PMC

Comment on

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. De Sousa E Melo F, Wang X, Jansen M, Fessler E, Trinh A, de Rooij LP, de Jong JH, de Boer OJ, van Leersum R, Bijlsma MF, et al. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions. Nat Med. 2013;19:614–8. doi: 10.1038/nm.3174. - DOI - PubMed
    1. Sadanandam A, Lyssiotis CA, Homicsko K, Collisson EA, Gibb WJ, Wullschleger S, Ostos LC, Lannon WA, Grotzinger C, Del Rio M, et al. A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat Med. 2013;19:619–25. doi: 10.1038/nm.3175. - DOI - PMC - PubMed
    1. Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010;138:2073–87, e3. doi: 10.1053/j.gastro.2009.12.064. - DOI - PMC - PubMed
    1. de Sousa E Melo F, Colak S, Buikhuisen J, Koster J, Cameron K, de Jong JH, Tuynman JB, Prasetyanti PR, Fessler E, van den Bergh SP, et al. Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients. Cell Stem Cell. 2011;9:476–85. doi: 10.1016/j.stem.2011.10.008. - DOI - PubMed
    1. Merlos-Suárez A, Barriga FM, Jung P, Iglesias M, Céspedes MV, Rossell D, Sevillano M, Hernando-Momblona X, da Silva-Diz V, Muñoz P, et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell. 2011;8:511–24. doi: 10.1016/j.stem.2011.02.020. - DOI - PubMed

Publication types

MeSH terms